Insider Transactions Reported by 21 Insiders of Tarsus Pharmaceuticals, Inc.

Symbol
TARS on Nasdaq
Location
Irvine, CA

Insiders trading volume in the past year

Tarsus Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bobak R. Azamian President/CEO and Board Chair, Director $66,657,374 -$2,590,360 -3.7% 24 Dec 2025
Vivo Capital IX, LLC 10%+ Owner $49,380,020 05 May 2022
RTW INVESTMENTS, LP 10%+ Owner $40,272,020 07 May 2021
Michael Ackermann Director $26,438,110 16 Jun 2022
WILLIAM J. LINK PHD Director $10,614,468 -$3,410,290 -24% 15 Dec 2025
Seshadri Neervannan Chief Operating Officer $6,605,949 -$363,142 -5.2% 16 Dec 2025
Elizabeth Yeu Lin Chief Medical Officer $3,555,607 -$206,527 -5.5% 15 Dec 2025
Bryan Wahl General Counsel $3,205,373 -$463,766 -13% 18 Mar 2025
Aziz Mottiwala Chief Commercial Officer $2,761,491 -$1,271,656 -32% 09 Jun 2025
Dianne C. Whitfield Chief Human Resources Officer $2,554,066 -$2,169,507 -46% 02 Jan 2026
Jeffrey Farrow Chief Financial Officer and Chief Strategy Officer $2,130,310 -$728,342 -25% 16 Jun 2025
Leonard Greenstein Chief Financial Officer $1,194,724 20 Apr 2023
Jose M. Trevejo Chief Medical Officer $914,003 20 Dec 2023
Andrew D. Goldberg Director $790,912 12 Jun 2025
WENDY L. YARNO Director $703,782 12 Jun 2025
Scott W. Morrison Director $478,964 15 Sep 2025
BHASKAR CHAUDHURI Director $466,982 12 Jun 2025
Katherine Goodrich Director $287,651 12 Jun 2025
Rosemary A. Crane Director $201,915 24 Jun 2024
Mark J. Holdbrook V.P., Clinical Affairs $193,631 17 Mar 2023
Jason E. Tester Director, 10%+ Owner $109,900 15 Jun 2021

Recent Insider Transactions by Companies or Individuals for Tarsus Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.